21 patients in limbo as talks on funding life-saving drug Respreza break down

Irish patients are set to lose access to life-saving lung disease drug Respreza.

Talks on funding Respreza have collapsed between the HSE and CSL Behring, the pharmaceutical company which makes it.

Twenty-one people suffering from a genetic lung disease called Alpha 1 have been using it for more than 11 years.

They were told last Friday that they will lose access to a vital drug called Respreeza at the end of the month.

Patient Gerry Finnerty from Kinsealy in North Dublin, who is 59, said: "Nobody knows what's going to happen to (us).

"There's no drug there even to ease you off - there's just a striaght trap door: 'There: it's done'."

In a statement last week CSL Behring said: “We remain committed to AATD research to improve the quality of life of people living with the condition. Based on this commitment, we are currently in discussion with health authorities in both the US and Europe to finalise a randomised, non-placebo controlled study design which seeks to demonstrate the long-term safety and efficacy of Respreeza.

“CSL Behring is evaluating clinical sites in Ireland which may then be offered the opportunity to recruit severe AATD patients.”


Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Red C poll sees two main parties make gains

INTO denies reports it has accepted new public service pay deal

PSNI appeal for information after man is found in Belfast with facial injuries

Traffic delays blamed after Dublin Half-Marathon starts an hour late


Today's Stories

Irish agriculture urged to diversify

Anger at ‘back door’ to water charges

Hospital maternity IT system rollout on hold

Theresa May’s speech did not go far enough, says Taoiseach

Lifestyle

House cleaning for dummies

Getting clean and lean: James Duigan on the simplicity of changing your food habits

Ask Audrey: You’re 9 on the Crazy Scale, where 1 is sane and 10 is flying with Ryanair

Get out and enjoy: What's on offer for Culture Night?

More From The Irish Examiner